Min et al. (2019) also offered a simple and efficient approach to correct exon 44 deletion mutations in the dystrophin gene, which is signified as one of the most shared causes of DMD, by CRISPR-Cas9 gene editing (Min et al., 2019). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.